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Abstract
Background: The C-type lectin DC-SIGN (CD209) is known to be the major dengue receptor on human dendritic cells, and a
single nucleotide polymorphism (SNP) in the promoter region of CD209 (2336 A/G; rs4804803) is susceptible to many
infectious diseases. We reason that variations in the DC-SIGN gene might have a broad influence on viral replication and
host immune responses.
Methods and Findings: We studied whether the rs4804803 SNP was associated with a susceptibility to dengue fever (DF)
and/or dengue hemorrhagic fever (DHF) through genotyping analysis in a Taiwanese cohort. We generated monocyte-
derived dendritic cells (MDDCs) from individuals with AA or AG genotype of rs4804803 to study the viral replication and
immune responses for functional validation. A total of 574 DNA samples were genotyped, including 176 DF, 135 DHF, 143
other non-dengue febrile illnesses (OFI) and 120 population controls. A strong association between GG/AG genotypes of
rs4804803 and risk of DHF was found when compared among DF, OFI and controls (p=0.004, 3610
25 and 0.001,
respectively). The AA genotype was associated with protection against dengue infection compared with OFI and controls
(p=0.002 and 0.020, respectively). Moreover, MDDCs from individuals with AG genotype with a higher cell surface DC-SIGN
expression had a significantly higher TNFa, IL-12p40, and IP-10 production than those with AA genotype in response to
dengue infection. However, the viral replication in MDDCs with AG genotype was significantly lower than those with AA
genotype. With both genotypes, MDDCs revealed an increase in viral replication following the addition of anti-IP-10
neutralizing antibody.
Conclusions/Significance: The rs4804803 SNP in the CD209 promoter contributed to susceptibility to dengue infection and
complication of DHF. This SNP with AG genotype affects the cell surface DC-SIGN expression related to immune
augmentation and less viral replication.
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Introduction
Dengue viruses (DEN) are arthropod-borne flaviviruses that
cause dengue fever (DF) with significant morbidity and mortality
in tropical and subtropical regions of the world. There are four
serotypes of dengue viruses (DEN types 1–4). Classic DF is a self-
limited illness characterized by fever, headache, myalgia, arthral-
gia, and abdominal pain. Since the 1950s, a more severe form of
the disease, dengue hemorrhagic fever (DHF), has been recognized
worldwide [1]. Patients who develop DHF typically have initial
symptoms similar to those in DF patients, but develop cytokine-
storm-like plasma leakage manifested by hemoconcentration,
thrombocytopenia, ascites, and pleural effusion near the defever-
ence stage [2]. DHF pathogenesis has been attributed to viral
virulence versus immune enhancement; however, that has been
the subject of debate for many years [2,3].
The innate immune system is the first line of host defense
against pathogens and is involved in early recognition and uptake
of microbes by the host’s professional phagocytes such as dendritic
cells (DCs) and macrophages, through germline-encoded recep-
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PRRs recognize microbial antigens and initiate innate immune
responses followed by adaptive immunity [5]. PRRs are involved
in phagocytosis, antigen presentation, and they trigger intracellular
signaling and cytokine secretion [5]. PRR polymorphisms may
therefore affect virus entry, replication, and immunity.
Among the PRRs, the CD209 molecule, also known as DC-
SIGN (dendritic cell-specific intercellular adhesion molecule-3
grabbing non-integrin), plays an important role in the early
interaction of a pathogen with a dendritic cell [6–8] and has a key
role in DC-T cell interaction [9], DC migration [10,11], and
pathogen uptake [12]. DC-SIGN is organized into three domains,
the N-terminal domain is located in the cytoplasm, the
transmembrane domain anchors to the cytoplasmic membrane,
and the extracellular domain consists of a neck region formed by
seven highly conserved 23 amino acid repeats and a carbohydrate
domain for pathogen binding [13].
The CD209 gene is located on chromosome 19p13.2–3 and is
highly polymorphic. Numerous single nucleotide polymorphisms
(SNPs) have been reported [14–18]. One of these SNPs represents a
guanine (G) to adenine (A) transition at position 2336 within the
CD209 gene promoter (rs4804803).Thisvariant hasbeenassociated
with an increased risk for parenteral acquisition of human
immunodeficiency virus (HIV) infection [15], severity of dengue
infection [16], and confered high susceptibility to tuberculosis in a
South African cohort [17]. Nevertheless, Vannberg et al. found that
G variant allele of rs4804803 was associated with protection against
tuberculosis in individuals from sub-Saharan Africa [18]. This
variant affects CD209 promoter activity with multiple transcription
factor binding sites for the Sp1/GATA1/CACCC- and CAC-
binding transcription factors in a transfection study [16]. As an in
vitro study of promoter activity might not reflect an actual functional
association, we aimed to test whether the rs4804803 SNP in the
promoter region of CD209 was associated with the susceptibility to
DF and/or DHF in Taiwanese, and whether monocyte-derived
DCs from humans with various genotypes of rs4804803 would
reveal differences in DC-SIGN membrane expressionand implicate
the viral replication and immune reactions after DEN infection.
Materials and Methods
Ethics statement and subjects studied
This study was approved by the Institution Review Board (IRB)
of Chang Gung Memorial Hospital-Kaohsiung Medical Center,
Taiwan. The dengue patients were recruited as described
previously in the 2002–2003 DEN-2 outbreak in Taiwan [19–
23]. A larger retrospective cohort was designed and re-approved
by an additional IRB review (Document No.: 97-2111B). To
validate cell surface expression and immune functions of
rs4804803 SNP, we obtained informed consent to collect blood
leukocytes from normal volunteers with AA or AG genotypes of
rs4804803.
Definition of cases and controls
DEN infection was confirmed by clinical dengue symptoms and
signs along with detection of DEN-2 RNA by quantitative RT-
PCR in blood, detection of IgM to DEN or at least a 4-fold
increase in dengue-specific hemagglutination inhibition titers in
convalescent serum compared with that in acute-phase serum
[20,21]. In those with DEN-2 infection, blood was drawn at least
once a day subsequent to admission into the hospital to measure
the platelet counts and hematocrit levels. A Chest X-ray and
abdominal ultrasonography were performed routinely in individ-
uals without evidence of hemoconcentration or hypoalbuminemia
to refine the differential diagnosis of DHF vs. DF based on pleural
effusion or ascites. A clinical diagnosis of DHF was assigned
according to the DHF criteria of the World Health Organization
(WHO); including a reduced platelet count (,100,000/mm
3),
petechiae, hemorrhagic manifestation, and plasma leakage
showing hemoconcentration (peak hematocrit $20% above the
mean for the population, or an increase in hematocrit of 20% or
more), pleural effusion, ascites, or hypoalbuminemia [24]. Patients
with DF were defined by detectable DEN-2 RNA by RT-PCR or
DEN-specific IgM, but without evidence of DHF. Primary or
secondary DEN infections were identified using previously
established serologic criteria for IgM/IgG ELISAs [19].
Patients with other non-dengue febrile illnesses (OFI) were
defined by febrile illness with no detectable DEN-specific IgM, no
detectable DEN RNA, and no obvious or reported bacterial
etiology for their illness during the same study period. Population
controls were healthy, unrelated volunteers from the same
community, with neither signs nor previous history of dengue
infection, with a DEN IgG sero-positive rate of 1.37% (1/73).
Genotyping of CD209 rs4804803 SNP
Genomic DNA was isolated from heparin-anticoagulated blood
samples using a standard phenol-chloroform extraction followed
by 70% alcohol precipitation. Genotyping for the CD209 variant
(2336 A/G; rs4804803) was carried out using Custom TaqMan
SNP Genotyping Assays (Applied Biosystems, Foster City, CA,
USA). The primer sequences were 59-GGACAGTGCTTCCAG-
GAACT-39 (forward) and 59-TGTGTTACACCCCCTCCAC-
TAG-39 (reverse). The TaqMan minor groove binder probe
sequences were 59-TACCTGCCTACCCTT G-39, and 59-
CTGCCCACC CTTG-39. The probes were labeled with the
TaqMan fluorescent dyes VIC and FAM, respectively. The PCR
was conducted in total volume of 15 mL using the following
amplification protocol: denaturation at 95uC for 10 min, followed
by 40 cycles of denaturation at 94uC for 20 s, followed by
annealing and extension at 60uC for one minute. After the PCR,
the genotype of each sample was determined by measuring the
allele-specific fluorescence in the ABI Prism 7500 Sequence
Detection System, using SDS 1.1 software for allele discrimination
Author Summary
Dengue fever (DF) is an arthropod-borne disease that is
prevalent in tropical and subtropical regions of the world.
DC-SIGN [dendritic cell-specific intercellular adhesion
molecule 3 (ICAM-3)-grabbing non-integrin] is a major
receptor for dengue infection. DC-SIGN, also called CD209,
expresses on dendritic cells (DCs) that bind to ICAM-3,
which is expressed on T cells to facilitate the initial
interaction between DCs and T cells. Variations in the
CD209 promoter (2336 A/G; rs4804803) genotype are
involved in the pathogenesis of human infectious diseases.
Here we found that patients with dengue hemorrhagic
fever (DHF) had a higher frequency of the AG or GG
genotype of rs4804803 than DF or controls. Functional
studies determined that monocyte-derived DCs (MDDCs)
from individuals with AG genotype had significantly higher
cell surface DC-SIGN expression, associated with higher
TNFa, IL-12p40, and IP-10 production, but lower viral
replication than those with AA genotype. An increase in
DEN-2 replication in MDDCs was observed following the
addition of anti-IP-10 neutralizing antibody. These findings
highlight the fact that the rs4804803 SNP in the CD209
promoter is associated with DHF and correlated to DC-
SIGN expression and immune augmentation.
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PCR analysis, 100 PCR products were subject to restriction
fragment length polymorphism (RFLP) analysis with MscI
restriction enzyme (New England Biolabs, Beverly, MA, USA)
and showed 100% identical result between these two genotyping
systems.
Generation of DCs from individuals with AA or AG
phenotype of rs4804803
Peripheral blood mononuclear cells were collected from
peripheral blood of 20 healthy, DEN-specific IgM or IgG
seronegative volunteers with AA or AG genotype. CD14
+
monocytes were isolated by positive selection according to the
manufacturer’s specifications using CD14 microbeads and a
magnetic cell separator (MACS) (Miltenyi Biotec, Bergisch
Gladbach, Germany). Enriched CD14
+ cells (purity.95%) were
cultured for 6 days in six-well plates in complete RPMI medium in
the presence of 10 ng/mL rhGM-CSF and 5 ng/mL rhIL-4 at
37uC, and 5% CO2. On day 3, half of the medium was replaced
with fresh medium supplemented with rhGM-CSF and rhIL-4.
Expression of markers was measured by flow cytometer using
specific antibodies and their corresponding isotype controls.
DCs infection with DEN-2 and endogenous IP-10
neutralizing experiments
Unless otherwise stated, monocyte-derived dendritic cells
(MDDCs) were infected with DEN-2 at a multiplicity of infection
(MOI) of 5 for 2 h at 37uC and 5% CO2. Cells were washed twice
to remove cell-free virus, and cultured in complete RPMI medium
(without cytokines) at a density of 2610
5 cells/ml in 48-well plates.
Cells and supernatants were removed and analyzed at 24, 48, and
72 h post-infection. For the neutralization experiments, cells were
incubated in the medium alone or in the medium with the addition
of anti-human CXCL10/IP-10 antibody (R&D Systems, Minne-
apolis, MN, USA) at 10 mg/mL for 30 min. Cells and superna-
tants were harvested and analyzed 24 h post-infection.
Detection of CD209 mRNA by real time RT-PCR and cell
surface expression on MDDCs by flow cytometry
TotalRNAextractedfromMDDCswassubjectedtoquantitative
RT-PCR to assess levels of mRNA corresponding to CD209 and
ß2–microglobulin (B2MG) using the ABI PRISM 7500 instrument
(Applied Biosystems). The forward primer, reverse primer sequence
for detecting CD209 and B2MG were 59-AACAGCTGAGAG-
GCCTTGGA-39,5 9-GGGACCATGGCCAAGACA-39, and 59-
AATTGAAAAAGTGGAGCATTCAGA-39,5 9-GGCTGTGAC-
AAAGTCACATGGTT-39, respectively. The PCR cycling param-
eters were 40 cycles of PCRreactions at 94uC for 20 s, and 60uC for
one minute. The results were detected in real-time and recorded on
a plot showing fluorescence vs. time. RT-PCR products were also
visualized on ethidium bromide-stained 1.5% agarose (Pierce Co.,
Rockford, IL, USA) gel with a 100- bp ladder (Pharmacia Biotech,
Piscataway, NJ, USA) as a reference.
T om e a s u r et h eC D 2 0 9c e l ls u r f a c ee x p r e s s i o n ,M D D C sw e r e
stained with FITC-conjugated mAbs specific for DC-SIGN (R&D
Systems, Minneapolis, MN, USA). An isotype-matched FITC-labeled
control, mouse IgG2b (clone MOPC195, Immunotech, Beckman
Coulter, Fullerton, CA, USA) was included in each experiment.
Quantitation of viral replication in MDDCs by real time
RT-PCR
Total RNA extracted from MDDCs was subjected to assess
DEN-2 RNA viral copies. Fluorescent RT-PCR was performed in
an ABI 7500 quantitative PCR machine (Applied Biosystems) for
40 cycles using TaqMan technology as previously described [21].
Table 1. Demographic data of dengue patients with DF and
DHF.
DF (n=176) DHF (n=135) p value
Age (years) 41.761.6 45.761.3 ,0.001
Sex (male/female) 86/90 60/75 0.439
Hematocrit (%) 37.060.1 39.763.0 0.021
Hemoconcentration
# (%) 6.060.6 20.761.3 ,0.001
Platelet (610
4/mm
3)1 0 . 9 60.7 2.660.3 ,0.001
WBC (/mm
3) 4,1306190 4,3746238 0.425
GOT (U/mL) 70.168.1 313.8674.6 0.002
GPT (U/mL) 67.1611.3 142.7621.9 0.003
Serum albumin level (g/dL) 3.760.2 3.160.1 0.001
Pleural effusion (%) 0/59 (0) 57/75 (76) ,0.001
Ascites (%) 1/68 (1) 47/85 (55) ,0.001
Secondary infection (%) 63/173 (36) 78/120 (65) ,0.001
*Values are the mean 6 SEM or number (%). P values were determined by
application of Student’s t-test for continuous variables and by X
2 test or Fisher
exact test for categorical variables.
#Defined as a 20% increase in hematocrit between the highest and lowest levels.
doi:10.1371/journal.pntd.0000934.t001
Table 2. Distribution of CD209 2336 A/G (rs4804803) genotype in patients with dengue infection (DEN) and other non-dengue
febrile illnesses (OFI) or population controls.
Genotype distribution Case vs. OFI Cases vs. Control DHF vs. DF
GG AG AA OR ( 95% CI) pO R ( 95% CI) pO R ( 95% CI) p
OFI (143) 0 (0) 8 (5.6) 135 (94.4) 1
Control (120) 0 (0) 9 (7.5) 111 (92.5) 1.37 (0.51–3.66) 0.531 1
DEN (311) 2 (0.6) 48 (15.4) 261 (83.9) 3.23 (1.49–7.02) 0.002 2.36 (1.12–4.97) 0.020
DF (176) 0 (0) 19 (10.8) 157 (89.2) 2.04 (0.87–4.81) 0.097 1.49 (0.65–3.42) 0.342 1
DHF (135) 2 (1.5) 29 (21.5) 104 (77.0) 5.03 (2.22–11.40) 3610
25 3.68 (1.67–8.09) 0.001 2.46 (1.32–4.59) 0.004
Values are number (%) studied. P value was determined by X
2 test or Fisher exact test based on GG or GA vs. AA comparison OR, odds ratio. CI, confidence interval.
doi:10.1371/journal.pntd.0000934.t002
CD209 -336A/G Correlated to DHF & Altered Immunity
www.plosntds.org 3 January 2011 | Volume 5 | Issue 1 | e934Detection of cytokine/chemokine production by ELISA
Cytokine/chemokine production and viral replication were
determined at 24, 48, and 72 h post-infection. Cell-free culture
supernatants TNFa and macrophage chemoattractant protein 1
(MCP-1) concentrations were measured using ELISA kits from
eBioscience Inc. (San Diego, CA, USA); IL-12p40 and IFN-
inducible protein 10 (IP-10) concentrations were measured using
ELISA kits from R&D Systems as per manufacturer’s instructions.
Statistical Analyses
Data are presented as mean 6 SEM values. Alleles and
genotypes distribution of rs4804803 are presented as numbers
(percentages). Conformance of the allele frequencies to Hardy-
Weinberg equilibrium proportions was tested to compare the
observed and expected frequencies of heterozygotes and homozy-
gotes. Differences among patients with DEN, DF, DHF, OFI, and
population controls were determined using two-sided Chi-Square
test or Fisher exact test. Odds ratio (OR) values were calculated
with 95% confidence intervals (CI). The Student’s t-test or Mann-
Whitney U test was used for statistical comparisons between
continuous variables. The Wilcoxon signed-rank test was used for
statistical comparison of the neutralization experiments. All
analyses were performed using SPSS 13.0 (SPSS Inc. Chicago,
IL, USA).
Results
Demographic characteristics of patients with DF and DHF
During a large DEN-2 outbreak in southern Taiwan between
June 2002 and January 2003, a hospital-based case-control study
was used to identify the risk immune parameters [19–23].
Employing the decoded DNA samples from that same cohort of
the population that study has been extended to investigate the
association of rs4804803 SNP with DF, DHF, viral replication,
and immune response. Based on the previous case-control study
design, we have included DNA samples from 135 DHF, 176 DF,
and 143 OFI patients in this expanded study. The main
characteristics of the study population are summarized in
Table 1. There were no significant differences in sex or total
leukocyte counts between patients with DF and those with DHF.
However, age (41.761.6 years vs. 45.761.3 years, p,0.001),
serum GOT levels (70.168.1 U/mL vs. 313.8674.6 U/mL,
p=0.002) and GPT levels (67.1611.3 U/mL vs. 142.7621.9 U/
mL, p=0.003) were significantly higher in the DHF group
(Table 1). A patient manifested with abdominal pain had ascites as
evidenced by abdominal ultrasonography was classified as DF
because the patient revealed no thrombocytopenia (,100,000/
mm
3), petechia or hemorrhagic manifestation during the admis-
sion period.
CD209 2336 A/G polymorphisms (rs4804803) associated
with dengue infection and DHF susceptibility
We investigated the association of rs4804803 SNP in the
promoter region of CD209 with protection from dengue infection
and the susceptibility of DHF. Genomic DNA obtained from DEN
patients (n=311), OFI patients (n=143), and population controls
(n=120) was genotyped for rs4804803 SNP. We found that GG/
AG genotypes in 16.0% of the DEN patients were significantly
higher than OFI patients (5.6%, OR=3.23, p=0.002) and
population controls (7.5%, OR=2.36, p=0.020; Table 2).
Moreover, the GG/AG genotypes were significantly higher in
DHF patients (23.0%) than OFI patients and population controls
(OR=5.03 and 3.68, p=3 610
25 and 0.001), and also signifi-
cantly higher than DF patients (10.8%, OR=2.46; p=0.004;
Table 2).
Analysis of the allele distribution between DEN and OFI
patients or population controls showed that the G allele frequency
was higher in DEN patients (8.4%), compared with OFI patients
(2.8%, OR=3.17, p=0.002) or population controls (3.8%,
Table 3. Distribution of CD209 2336 A/G (rs4804803) allele in patients with dengue infection (DEN) and other non-dengue febrile
illnesses (OFI) or population controls.
Allele distribution Cases vs. OFI Cases vs. Control DHF vs. DF
GA OR ( 95% CI) pO R ( 95% CI) pO R ( 95% CI) p
OFI 8 (2.8) 278 (97.2) 1
Control 9 (3.8) 231 (96.2) 1.35 (0.51–3.57) 0.538 1
DEN 52 (8.4) 570 (91.6) 3.17 (1.49–6.77) 0.002 2.34 (1.14–4.83) 0.018
DF 19 (5.4) 333 (94.6) 1.98 (0.86–4.60) 0.105 1.46 (0.65–3.29) 0.354 1
DHF 33 (12.2) 237 (87.8) 4.84 (2.19–10.68) 2610
25 3.57 (1.67–7.63) 0.001 2.44 (1.36–4.40) 0.002
Values are number (%) studied. P value was determined by X
2 test or Fisher exact test OR, odds ratio. CI, confidence interval.
doi:10.1371/journal.pntd.0000934.t003
Table 4. Distribution of CD209 2336 A/G genotype in patients with primary and secondary dengue infection.
DF DHF
GG AG AA OR ( 95% CI) p GG AG AA OR ( 95% CI) p
Primary (152) 0 (0) 13 (11.8) 97 (88.2) 1 0 (0) 6 (14.3) 36 (85.7) 1
Secondary (141) 0 (0) 5 (7.9) 58 (92.1) 0.64 (0.22–1.90) 0.409 2 (2.6) 16 (20.5) 60 (76.9) 1.80 (0.65–4.95) 0.251
Values are number (%) studied. P value was determined by X
2 test or Fisher exact test based on GG or GA vs. AA comparison. OR, odds ratio. CI, confidence interval.
Primary and secondary dengue infections are defined by detectable DEN-specific IgM and IgG, respectively, within one week of the illness.
doi:10.1371/journal.pntd.0000934.t004
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of rs4804803 was significantly higher in DHF patients (12.2%) than
OFI patients or population controls (OR=4.84 and 3.57, p=
2610
25 and 0.001), and higher than DF patients (5.4%, OR=2.44,
p=0.002; Table 3). Few DHF patients (n=6) had dengue shock
syndrome in this cohort; one of them carrying AG genotype.
No association of CD209 2336 A/G polymorphism
(rs4804803) with primary and secondary dengue
infection
To investigate whether the rs4804803 SNP in the promoter
region of CD209 associated with the primary and secondary DEN
infection, we used serological methods to detect DEN antibodies for
differentiation into primary and secondary dengue infection. Of the
293 DEN patients, 141 (48%) had secondary DEN infections, based
on detectable DEN-2 virus RNA and DEN IgG. As shown in
Table 1, secondary DEN-2 infection was more frequently found in
patients with DHF than in those with DF (65% vs. 36%, p,0.001).
We found the rs4804803 GG/AG genotypes were found in 12.5%
of patients with primary DEN infection and 16.3% of patients with
secondaryDENinfection,which didnotreachsignificantlydifferent
(OR=1.36; p=0.352). As shown in Table 4, there was no
association between rs4804803 SNP and primary or secondary
dengue infection in DF patients (OR=0.64; p=0.409), or in DHF
patients (OR=1.80; p=0.251). In addition, there was no
association between allele distribution and primary or secondary
dengue infection in DF and DHF patients (data not shown).
Increase of DC-SIGN expression on MDDCs from
individuals with AG genotype of rs4804803
Due to the low frequency of GG genotype in our population (2
cases, 0.6%), we could not recall the patients because the data file
Figure 1. CD209 mRNA and cell surface expression on MDDCs with AA or AG genotype of rs4804803. (A) Quantitative RT-PCR analysis of
CD209 mRNA in MDDCs was run parallel to ß2-microglobulin (B2MG) mRNA expression (control) on the real-time RT-PCR tracing and the gel view of
RT-PCR products. (B) Subjects with rs4804803 AG genotype had higher CD209 mRNA expression in MDDCs than those with AA genotype (p=0.032).
(C) Flow cytometric analysis of CD209 surface expression on MDDCs from individuals with the rs4804803 AG genotype (blue line; MFI=34.1) and with
the AA genotype (black line; MFI=30.4). (D) MDDCs from individuals with AG genotype had significantly higher CD209 cell surface expression than
those with AA genotype (p=0.029). The results are shown as mean 6 s.e.m. from subjects with AA (n=10) or AG (n=10) genotype in three
independent experiments. Statistical values were determined by Mann-Whitney U test. Asterisk (*) indicates a significant difference (p,0.05).
doi:10.1371/journal.pntd.0000934.g001
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(CD209) expression in both mRNA level of MDDCs and protein
level on their cell surface from healthy subjects with AA or AG
genotype by quantitative RT-PCR and flow cytometry, respec-
tively. A significant increase in CD209 mRNA expression was
detected in the MDDCs from individuals with AG genotype than
those from individuals with AA genotype (p=0.032, Fig 1B).
Similarly, individuals with AG genotype had a significantly
higher cell surface DC-SIGN expression (p=0.029; Fig 1D).
However, the surface DC-SIGN expression declined rapidly
along with DEN-2 infection on MDDCs from both genotypes’
subjects, which showed no difference at 24, 48, and 72 h post-
infection (Fig. 2A).
Lower viral replication in MDDCs from individuals with
AG genotype of rs4804803
To investigate whether the rs4804803 SNP was correlated to
viral replication, we measured DEN-2 RNA copies in MDDCs
with AA or AG genotype of rs4804803 at 24, 48, and 72 h post-
infection. DEN-2 replication was significantly higher in MDDCs
from individuals with AA genotype than those with AG genotype
at 48 h post-infection (1.0760.45610
6 copies/10
5 cells vs.
3.9060.67610
6 copies/10
5 cells, p=0.006) and 72 h post-
infection (4.8360.70610
5 copies/10
5 cells vs. 2.3260.68610
6
copies/10
5 cells, p=0.003; Fig. 2B). Viral replication, as measured
at 72 h post-infection, increased more remarkably in MDDCs at
MOI of 5 and 10 (p,0.001 and 0.002, respectively; Fig. 2C).
Elevation of cytokines TNFa, IL-12p40, and chemokine IP-
10 production in DEN-infected MDDCs with AG genotype
of rs4804803
To investigate whether higher cell surface DC-SIGN expression
was correlated with immune response, we investigated kinetic
cytokine/chemokine production by MDDCs from individuals with
AA or AG genotype of rs4804803. Results showed that MDDCs
with AG genotype had significantly higher TNFa production than
those with AA genotype at 24 and 48 hr post-infection (303.516
66.75 pg/mL vs. 143.97668.80 pg/mL and 202.35619.35 pg/
mL vs. 73.0069.55 pg/mL; p=0.021 and 0.002, respectively;
Fig 3A). IL-12p40 production significantly increased by MDDCs
with AG genotype than those with AA genotype at 24, 48, and
72 h post-infection (p,0.001, 0.007 and 0.001, respectively;
Fig 3B). We also measured the concentration of two chemokines,
MCP-1 and IP-10, which had been implicated in the recruitment
and stimulation of monocytes, macrophages, dendritic cells, NK
cells, and T lymphocytes [25]. It was found that IP-10, but not
MCP-1, production was significantly higher by MDDCs with
AG genotype than those with AA genotype at 24, 48, and 72 h
post-infection (620.606175.56 pg/mL vs. 243.02641.64 pg/mL,
889.92691.46 pg/ml vs. 168.02624.02 pg/mL, and 614.446
49.16 pg/mL vs. 322.32669.62 pg/mL; p=0.034, 0.009 and
0.010, respectively; Fig 3C). The MCP-1 levels peaked at 48 hr
in subjects with both genotypes’, but there was no significant
difference between AA genotype and AG genotype (550.726
60.73 pg/mL vs. 463.92666.80 pg/mL, p=0.157; Fig. 3D).
Figure 2. Kinetic surface CD209 expression and viral replica-
tion from DEN-infected MDDCs with AA or AG genotype. (A)
Kinetic CD209 surface expression on MDDCs from individuals with AA
or AG genotype of rs4804803 by flow cytometry. The surface CD209
expression declined along with infection in subjects with both
genotypes. (B) Kinetic changes of DEN-2 replication (virus copies per
10
5 cells) were assessed after infection at MOI of 5 for 24 to 72 h. Viral
replication was significantly higher in MDDCs from individuals with
rs4804803 AA genotype than those with AG genotype at 48 hr and
72 hr post-infection (p=0.006 and 0.003, respectively) The results are
shown as mean 6 s.e.m. from subjects with AA (n=8) or AG (n=8)
genotype in three independent experiments. (C) Changes in the yield of
DEN-2 replication (virus copies per 10
5 cells) were assessed at MOIs of 1,
5, and 10 at 72 h post-infection. Viral replication was significantly higher
in MDDCs from individuals with AA genotype than those with AG
genotype at MOIs of 5 and 10 (p,0.001 and 0.002, respectively). The
results are shown as mean 6 s.e.m. from subjects with AA (n=10) or AG
(n=10) genotype in three independent experiments. Statistical values
were determined by Mann-Whitney U test. Asterisk (*) indicates a
significant difference (p,0.05). ** indicates p,0.01; *** p,0.001.
doi:10.1371/journal.pntd.0000934.g002
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of DEN infection
IP-10, produced by non-infected bystander DCs in response to
DEN infection, is a potent chemoattractant for activated T and
NK cells [26], and the modulation of adaptive immune response
[27]. IP-10 has also been known to inhibit the binding ability of
DEN in immortalized cells [28]. In our MDDC model, cells from
individuals with AG genotype exhibited an augmented innate
immune reaction, showing higher IP-10 production, post-infection
(Figure 3C). Based on these results, we hypothesized that DEN-
infected MDDCs with AG genotype produced higher levels of IP-
10, which might block viral entry or viral replication in MDDCs.
We used an anti-IP-10 neutralizing mAb to block endogenous IP-
10 production by MDDCs. With both genotypes, the viral
replication 24 h post DEN infection increased significantly more
in the presence of neutralizing antibody than in the absence of
neutralizing antibody (p=0.034 and 0.040, respectively; Fig. 4A).
IP-10 production by MDDCs from individuals with AG genotype
significantly decreased (795.36368.1 pg/mL vs. 273.8687.8 pg/
mL; p=0.037), but it did not decrease in MDDCs from individuals
with AA genotype (329.86114.2 pg/mL vs. 201.8687.0 pg/mL;
p=0.091; Fig. 4B). These results suggest that IP-10 produced by
MDDCs is involved in the viral replication of DEN infection.
Discussion
DC-SIGN has been shown to be an important receptor for
DEN and a number of viruses, including HIV, Helicobacter pylori,
and Mycobacterium tuberculosis and hepatitis C virus (HCV) [29].
Some studies have demonstrated that genetic variations of CD209
(rs4804803) were associated with the susceptibility to HIV [14],
Mycobacterium tuberculosis [17], HCV [30], and dengue [16]. Few
studies have demonstrated how the rs4804803 SNP is involved in
viral replication or immune response. We are the first in the field
to demonstrate the relationship among functional cell surface
expression, viral replication, and immune responses in DEN-
infected MDDCs from subjects with rs4804803 SNP. Here we
found that rs4804803 SNP was strongly associated with the risk of
DHF vs. DF and controls. Functional studies have determined that
Figure 3. Kinetic cytokine/chemokine production by DEN-infected MDDCs from individuals with AA or AG genotype of rs4804803.
The supernatant of TNFa, IL-12p40, IP-10 and MCP-1 levels were measured using ELISA after DEN infection at MOI of 5 for 24 to 72 h. The production
of TNFa (A), IL-12p40 (B), and IP-10 (C) levels after DEN-2 infection was significantly higher in MDDCs from individuals with AG genotype than those
with AA genotype. The production of MCP-1 (D) after DEN-2 infection was not significantly different between the two groups. The results are shown
as mean 6 s.e.m. from subjects with AA (n=8) or AG (n=8) genotype in three independent experiments. Statistical values were determined by
Mann-Whitney U test. Asterisk (*) indicates a significant difference (p,0.05). ** indicates p,0.01; *** p,0.001.
doi:10.1371/journal.pntd.0000934.g003
CD209 -336A/G Correlated to DHF & Altered Immunity
www.plosntds.org 7 January 2011 | Volume 5 | Issue 1 | e934MDDCs from individuals with AG genotype have a significantly
higher cell surface DC-SIGN expression than from those with AA
genotype. MDDCs with AG genotype produced higher TNFa, IL-
12p40, and IP-10 levels but lower viral replication in response to
dengue infection.
Because the physiopathology of various manifestations of DHF
is not fully understood, several studies have supported the
supposition that secondary dengue infection [31], age [32], a
number of preexisting chronic diseases such as diabetes and
bronchial asthma [33], and host genetic factor [16,22] increase the
risk of progression to DHF. This indicates that multiple factors are
involved in the development of DHF. Our findings regarding
rs4804806 SNP associated with DHF vs. OFI control (p=3 610
25;
Table 2) in a case-control association study suggests that
rs4804806 SNP contributes in part to the development of DHF.
Our study shows that the GG/AG genotypes of rs4804803 were
associated with susceptibility to DHF, compared with DF, which is
consistent with the observation of Sakuntabhai et al. [16]. In our
study, the AA genotype was associated with protection against
DHF, compared with OFI and population controls, while G allele
was associated with protection against DF in Sakuntabhai’s
observation. The inconsistency between these studies regarding
the protection for DHF or DF may result from two possibilities.
First, the frequency of G allele in Chinese population is 3.8%;
while in Thailand, it is 9.5–10.4% [16,34]. Second, definition of
DF and DHF might be also different. We defined DF and DHF
according to WHO criteria, while in the study by Sakuntabhai
et al., DF was defined by criteria of severe dengue fever syndrome
with hemorrhage but no plasma leakage, excluding patients with
flu-like symptoms or those having only fever. Moreover, the
rs4804803 SNP was demonstrated to be in linkage disequilibrium
with three other intronic polymorphisms in a Thai population, and
these might also have contributed to the susceptibility of DHF
[16].
Our results suggest that humans carrying the rs4804803 AG
genotype have a higher DC-SIGN expression and lower DEN-2
Figure 4. IP-10 production by MDDCs involved in the viral replication of DEN infection. MDDCs were mock-infected or DEN infected
(MOI=5) after preincubation, with and without anti-IP-10 neutralizing antibody (10 mg/mL) for 30 min. Total RNA was extracted from MDDCs and the
supernatants were collected 24 h post-infection. The percentage of viral replication (A) and the production of IP-10 levels (B) following DEN-2
infection were significantly higher by MDDCs from individuals with AG genotype than from individuals with AA genotype. Following DEN-2 infection,
the production of IP-10 by MDDCs from individuals with AA genotype was not significantly different between those with and without anti-IP-10
neutralizing antibody. The results are shown as mean 6 SEM from three independent experiments (n=7). Statistical values were determined by
Wilcoxon signed-rank test. Asterisk (*) indicates a significant difference (p,0.05).
doi:10.1371/journal.pntd.0000934.g004
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by Loach et al. who demonstrated that the DC-SIGN expression
levels on Raji cells after transfection of various DC-SIGN cDNA
constructs were significantly correlated to the infection rate of
DEN-1 [35]. DC-SIGN is an endocytic receptor shown to induce
endocytosis of several pathogens, including dengue [36–38]. The
difference between these two studies might be due to different cell
types and ex vivo culture systems. In our study, it was found that
MDDCs from subjects with rs4804803 AG genotype had higher
surface DC-SIGN expression with higher production of chemo-
kines such as IP-10, which could limit DEN-2 replication (Fig. 4A);
however, the higher surface DC-SIGN expression in subjects with
AG genotype decreased remarkably 24 h post-infection (Fig. 2A).
In the study by Loach et al., ectopic expression levels of DC-SIGN
on Raji cells enhanced DEN-1 replication, which might be related
to a higher quantity of receptors or lower production of IP-10
favoring DEN replication. Results from these studies suggest that
the correlation of viral replication to higher or lower DC-SIGN
expression depends on genetic factors in the host, cell type, and
dynamic changes in the receptor following DEN infection.
In functional studies of rs4804803 SNP, we determined that
MDDCs with AG genotype had a higher DC-SIGN expression
correlated to augmented immune responses with higher TNFa,
IL-12p40, and IP-10, than those with AA genotype, but not MCP-
1 production. DEN replication was significantly lower in
individuals with AG genotype. The addition of anti-IP-10
neutralizing antibody blocked the production of endogenous IP-
10 and significantly enhanced the replication of DEN-2 (Fig. 4A).
This suggests that rs4804803 SNP was involved in the DC-SIGN
expression associated with augmented immune response, such as
the increase in the production of IP-10 that repressed the
replication of DEN. This is supported by the fact that altered
immune response, but not viral load, was observed in DHF
patients [21,39]. CLEC5A-mediated DEN infection in animals
that was susceptible to DEN hemorrhagic infection also revealed
augmented immune response [40].
In contrast, it is interesting to note that the viral replication in
MDDCs from individuals with rs4804803 AA genotype was
significantly higher than in individuals with AG genotype
following DEN-2 infection. The mechanism by which rs4804803
SNP influences DEN replication in MDDCs is currently unknown.
Chan et al. showed that certain polymorphisms of L-SIGN,aDC-
SIGN homologue, mediated more efficient viral degradation of
SARS-CoV [41]. The clinical implications of screening genotypes
to prevent DEN infection might be supported if different viral
loads could be demonstrated among humans with various
genotypes of rs4804803 in future outbreaks of DEN.
The outcome of DEN infection is determined by a myriad of
interactions among viral, immunological, and human genetic
factors, as well as kinetic interactions between innate and adaptive
immunity. This study provides new evidence that CD209
rs4804803 SNP, correlated to cell surface expression on dendritic
cells, mediates augmented immune responses against DEN-2
infection and is implicated in the susceptibility of DHF. Further
studies are warranted, particularly with regard to the genetic
variants of CD209 on the DC polarization of adaptive immunity,
and how they may promote or protect the development of DHF.
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